Biden to speed up vaccinations; second dose shortage unlikely, advisers say
By
Alicia Lasek
Jan 15, 2021
Biden aims to have 100 million vaccines administered in his first 100 days. Meetings with manufacturers have bolstered confidence that supply will steadily increase, an advisory board member said.
In breakthrough, feds OK nursing home visits, group dining and activities; update infection control guidance
By
Alicia Lasek
Apr 28, 2021
After nearly a year in lockdown, nursing home residents can participate in indoor visitation, communal dining and group activities — with exceptions, the Centers for Disease Control and Prevention announced...
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
CDC briefing: Top officials talk up vaccine plans, focus on long-term care
By
Alicia Lasek
Oct 22, 2020
Federal health officials touted transparency and nationwide distribution plans while keeping their eye on Phase 1 vaccine recipients, including LTC residents and workers.
Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.
Resident poll reveals pandemic’s emotional toll: Frail elders need ‘something to live for’
By
Alicia Lasek
Oct 02, 2020
A direct poll of nursing home residents in 36 states reveals a “drastic” reduction in social activities and a steep increase in reported loneliness. “Innovative distance socializing” may help address...